Novo Nordisk, maker of the blockbuster drugs for diabetes and weight loss respectively, has a market capitalisation of $592.02 billion, making it larger than the entire Danish economy. The company's global CEO talks about its India plans and the need for competition to ramp up innovation in pharma
Lars Fruergaard Jørgensen, CEO, Novo Nordisk; Image: Chris Ratcliffe/Bloomberg via Getty Images